Clinical Trials Logo

Filter by:
NCT ID: NCT02852018 Completed - Cardiomyopathy Clinical Trials

Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy

GENECHOC
Start date: January 2010
Phase: N/A
Study type: Observational

The aim of this project is to identify common genetic polymorphisms associated with the occurrence of rhythmic events in patients with severe cardiomyopathy.

NCT ID: NCT02851836 Completed - Clinical trials for Emotion Dysregulation

Attachment Image Data Set Validation in Adolescent

MONRADO1
Start date: October 2012
Phase: N/A
Study type: Interventional

this study aims to validate a picture data set that particularly activates the attachment process and that could be used in attachment studies.

NCT ID: NCT02851810 Completed - Clinical trials for Emotion Dysregulation

Oculomotor Markers and Attachment in Adolescents

MONRADO2
Start date: December 19, 2013
Phase: N/A
Study type: Interventional

The study aims to identify specific visual scanning patterns of attachment pictures in adolescent with different attachment style.

NCT ID: NCT02851797 Completed - Clinical trials for Duchenne Muscular Dystrophy

Clinical Study to Evaluate the Efficacy and Safety of Givinostat in Ambulant Patients With Duchenne Muscular Dystrophy

Start date: June 6, 2017
Phase: Phase 3
Study type: Interventional

Primary Objective The primary objective of the study was to establish the effects of givinostat versus placebo administered chronically over 18 months to slow disease progression in ambulant DMD subjects. Secondary Objectives The secondary objectives of this study were: - To assess the safety and tolerability of givinostat versus placebo administered chronically in DMD subjects - To evaluate the PK profile of givinostat administered chronically in DMD subjects - To evaluate the impact on quality of life (QoL) and activities of daily living of givinostat versus placebo administered chronically.

NCT ID: NCT02851771 Completed - Pneumonia Clinical Trials

Improving the Diagnosis of Pneumonia in Emergency Rooms

Start date: June 14, 2013
Phase: N/A
Study type: Interventional

A point-of-care laboratory (POC) was set at North Hospital, Marseille, France for the diagnosis in less than two hours of pneumonia caused by known pathogens, close to the reception of Emergency service. In this instance 30% of patients have no etiological diagnosis after the POC tests Pneumonia. This lab has discovered over 200 new species of bacteria in humans, including vector bacteria and opened the field of large Deoxyribo Nucleic Acid (DNA ) viruses. Also, the laboratory of emerging viruses discovered many Ribo Nucleic Acid (RNA) viruses transmitted by arthropods. Based on this collection of new pathogens described in POC laboratory, this study proposes to expand the etiological diagnosis strategy of pneumonia after POC tests.

NCT ID: NCT02851680 Completed - Clinical trials for Invasive Fungal Infections

Interest of ß 1-3 D Glucan Assays in Screening for the Onset of Invasive Aspergillosis in Neutropenic Patients With Acute Leukaemia.

BETA GLUCAN
Start date: September 2014
Phase: N/A
Study type: Interventional

In the context of screening for infectious fungal diseases in patients with malignant haemopathy, and particularly patients with acute leukaemia, the investigator aims to evaluate the performance of an already commercialized but little used serum screening test (Fungitell® test) and to determine its place in the management strategy for invasive aspergillosis.

NCT ID: NCT02851654 Completed - Dry Eye Syndromes Clinical Trials

Interest of Eye Movement Measurements in the Comprehension of Dry Eyes Symptoms

BOSO
Start date: November 5, 2014
Phase:
Study type: Observational

Dry eye syndrome is a benign situation however its impact on patient's quality of live and on health system is not trivial. One problem is the lack of correlation between patient's symptoms and physical sign observed on slit lamp examination. Eye blinking is a parameter of increased interest in this pathology particularly its frequency. To date no treatment of dry eye syndrome has a proven impact on eye blinking frequency. However recording of blinks has mostly been performed on short duration (3 to 5 minutes) and the distribution of intervals between 2 blinks is not gaussian but exponential. In this study, it is proposed to use modern eye-movement recorder to measure the blink frequency on longer duration (12 minutes) while reading on a screen computer and during a face-to-face interview before and after treatment of meibomian gland dysfunction responsible of moderate to severe dry eye syndrome.

NCT ID: NCT02851641 Completed - Clinical trials for Lacrimal Duct Obstruction

Risk and Importance of Peroperative Nasal Hemorrhage in the Treatment of Lacrimal Duct Obstruction in Young Children

CANALHEMO
Start date: September 2, 2015
Phase:
Study type: Observational

The aim of the study is to evaluate the risk in intra-operative nasal hemorrhage when using a "pushed" probe (Master Ka) in the treatment of naso lacrimal duct obstruction (NLDO). In the investigator's experience, this risk seemed to minus using a pushed probe rather than the classical pulled-type probes. A lower risk of hemorrhage could lead to a change in the anesthetic procedure. The gold standard in NLDO is the use of an orotracheal intubation. It could then be replaced by the use of an orolaryngeal mask. A forthcoming study will evaluate the results of this anesthetic change.

NCT ID: NCT02851602 Completed - Metabolic Syndrome Clinical Trials

Phospholipid and Sphingolipid Composition of High-density Lipoproteins (HDL) in Obese Non-diabetic Patients With Metabolic Syndrome

SPHINGO
Start date: November 18, 2013
Phase: N/A
Study type: Interventional

HDL in obese non-diabetic patients show major alterations in their function and thus their cardio-protective effects. These alterations could be explained by the quantitative and qualitative anomalies in the phospholipids and sphingolipids in the HDL. These molecules play a major role in HDL function and probably present early modifications in obesity, even before the onset of glycaemia deregulation. The aim of this study is to show the presence of qualitative and quantitative modifications of phospholipids and sphingolipids in HDL from obese patients compared with HDL from non-obese controls.

NCT ID: NCT02851576 Completed - Clinical trials for Adenovirus Infection

Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV)

CTL-ADV
Start date: August 2011
Phase: Phase 1/Phase 2
Study type: Interventional

Fourteen patients will be included for infusion of adenovirus-specific T-cells generated by a clinical grade IFN-γ based immunomagnetic isolation from a leukapheresis from their original donor or a haploidentical donor, in case of Umbilical cord blood transplantation, in the event of refractory ADV infection or disease.